SCOPUS 정보 검색 플랫폼

Annals of Pharmacotherapy

Volumn 35, Issue 6, 2001, Pages 698-701

Neuroleptic malignant syndrome during a change from haloperidol to risperidone

(3) Reeves, Roy R a,b Mack, James E a,b Torres, Rafael A a,b

a Veterans Administration (United States)

b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE (United States)

Author keywords

Haloperidol; Mirtazapine; Neuroleptic malignant syndrome; Risperidone

Indexed keywords

BROMOCRIPTINE; DANTROLENE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; MIRTAZAPINE; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; DOPAMINE RECEPTOR BLOCKING; DRUG POTENCY; FEVER; HUMAN; HYPERACTIVITY; MALE; MENTAL HEALTH; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; RELAPSE; RIGIDITY; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; RISPERIDONE; SCHIZOPHRENIA;

EID: 0035018959 PISSN: 10600280 EISSN: None Source Type: Journal
DOI: 10.1345/aph.10137 Document Type: Article

Times cited : (18)

References (29)

1
- 0000182562
- Un neuroleptique majeur nonphenothiazine et non-reserpinique, l'haloperidol, dans le traitement des psychoses
- (1960) Ann Med Psychol , vol.118 , pp. 145-152
- Delay, J.¹ Pichot, P.² Lemperiere, T.³ Elissalde, B.⁴ Peigne, F.⁵

2
- 0023877608
- A brief review of the 250 cases of NMS reported in the literature from 1980-7
- (1988) Psychopharmacol Bull , vol.24 , pp. 25-29
- Caroff, S.N.¹ Mann, S.C.²

3
- 0031850514
- Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique
- (1998) Am J Psychiatry , vol.155 , pp. 1113-1116
- Hasan, S.¹ Buckley, P.²

4
- 0030054382
- Risperidone-induced neuroleptic malignant syndrome
- (1996) Ann Pharmacother , vol.30 , pp. 775-778
- Sharma, R.¹ Trappler, B.² Ng, Y.K.³ Leeman, C.P.⁴

5
- 0033142688
- Olanzapine and NMS
- (1999) Psychiatr Serv , vol.50 , pp. 836-837
- Hickey, C.¹ Stewart, C.² Lippmann, S.³

6
- 0032948895
- Olanzapine-induced neuroleptic malignant syndrome
- (1999) Arch Gen Psychiatry , vol.56 , pp. 101-102
- Barkhard, P.R.¹ Vingerhoets, F.J.G.²

7
- 0022503130
- Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital
- (1986) Am J Psychiatry , vol.143 , pp. 1227-1233
- Pope, H.G.¹ Keck, P.E.² McElroy, S.L.³

8
- 0026521164
- A comparison of diagnostic criteria for neuroleptic malignant syndrome
- (1992) J Clin Psychiatry , vol.53 , pp. 56-62
- Gurrera, R.J.¹ Chang, S.S.² Romeo, J.A.³

9
- 0025369469
- Pathogenesis and treatment of neuroleptic malignant syndrome
- (1992) Gen Pharmacol , vol.21 , pp. 367-386
- Ebadi, M.¹ Pfeiffer, R.F.² Murrin, L.C.³

10
- 0023722512
- Neuroleptic malignant syndrome. The result of a 6 month prospective study of incidence in a state psychiatric hospital
- (1988) Clin Neuropharmacol , vol.11 , pp. 373-377
- Freidman, J.H.¹ Davis, R.² Wagner, R.³

11
- 0028027983
- Risperidone-induced neuroleptic malignant syndrome
- (1994) Lancet , vol.344 , pp. 1228-1229
- Webster, P.¹ Wijeratne, C.²

12
- 0028076286
- Risperidone-induced neuroleptic malignant syndrome in a young patient
- (1994) Lancet , vol.344 , pp. 1705
- Raitasuo, V.¹ Vataja, R.² Elomaa, E.³

13
- 0027994340
- Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent
- (1994) Hum Psychopharmacol , vol.9 , pp. 303-305
- Lee, H.¹ Ryan, J.² Mullett, G.³ Lawlor, B.A.⁴

14
- 0029353466
- Two cases of risperidone-induced neuroleptic malignant syndrome
- (1995) Am J Psychiatry , vol.152 , pp. 1233-1234
- Dave, M.¹

15
- 0028883360
- Risperidone and neuroleptic malignant syndrome, a case report
- (1995) J Clin Psychiatry , vol.56 , pp. 534-535
- Najara, J.E.¹ Enikeev, I.²

16
- 0029353466
- Two cases of risperidone-induced neuroleptic malignant syndrome
- (1995) Am J Psychiatry , vol.152 , pp. 1234
- Singer, S.¹ Richards, C.² Boland, R.J.³

17
- 0029103332
- Risperidone and NMS
- (1995) Psychiatric Serv , vol.46 , pp. 951
- Murray, S.¹ Haller, E.²

18
- 13344278699
- Risperidone and neuroleptic malignant syndrome
- (1996) JAMA , vol.275 , pp. 446
- Tarsey, D.¹

19
- 0029980667
- Delayed risperidone-induced neuroleptic malignant syndrome
- (1996) Ann Pharmacother , vol.30 , pp. 300
- Kem, J.L.¹ Cemek, P.K.²

20
- 0029880137
- Neuroleptic malignant syndrome with risperidone
- (1996) J Clin Psychopharmacol , vol.16 , pp. 192-193
- Levin, G.M.¹ Lazowick, A.L.² Powell, H.S.³

21
- 0030770416
- Atypical neuroleptic malignant syndrome associated with risperidone treatment
- (1997) Am J Psychiatry , vol.154 , pp. 1475
- Newman, M.¹ Adityanjee² Jampala, C.³

22
- 0030965302
- Neuroleptic malignant syndrome with risperidone
- (1997) Pharmacotherapy , vol.17 , pp. 617-621
- Gleason, P.P.¹ Conigliaro, R.L.²

23
- 0030728273
- Risperidone-induced neuroleptic malignant syndrome
- (1997) Ann Emerg Med , vol.30 , pp. 698-700
- Bajjaka, I.¹ Patel, T.² O'Sullivan, T.³

24
- 0026687980
- Distinguishing neuroleptic malignant syndrome from NMS-like acute illnesses
- (1992) J Neuropsychiatry Clin Neurosci , vol.4 , pp. 265-269
- Sewell, D.D.¹ Jeste, D.V.²

25
- 0001275867
- Dopamine receptor antagonists
- Kaplan BJ, Sadock BJ, eds. Baltimore: Williams and Wilkins
- (1995) Comprehensive textbook of psychiatry/VI , pp. 1987-2022
- Kammen, D.P.¹ Marder, S.R.²

26
- 0019799332
- A method for estimating the probability of adverse drug reactions
- (1981) Clin Pharmacol Ther , vol.30 , pp. 239-245
- Naranjo, C.A.¹ Busto, U.² Sellers, E.M.³ Sandor, P.⁴ Ruiz, I.⁵ Roberts, E.A.⁶

27
- 0033021534
- Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome
- (1999) Am J Psychiatry , vol.156 , pp. 169-180
- Gurrera, R.J.¹

28
- 0030763124
- Switching antipsychotic medications
- (1997) J Clin Psychiatry , vol.58 , pp. 63-72
- Weiden, P.J.¹ Aquila, R.² Dalheim, L.³ Standard, J.M.⁴

29
- 0032933361
- Conventional vs. newer antipsychotics in elderly patients
- (1999) Am J Geriatr Psychiatry , vol.7 , pp. 70-76
- Jeste, D.V.¹ Rockwell, E.² Harris, M.J.³ Lohr, J.B.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.